The CD117 Antibody Reagent is a specialized tool used in immunohistochemistry to detect the presence of CD117 antigen in human tissues. This reagent is essential for diagnosing various conditions, including gastrointestinal stromal tumors (GISTs), and is a critical component in the development of personalized treatment plans. Its high specificity and sensitivity make it a reliable choice for clinical laboratories.
1. The CD117 Antibody Reagent is known for its high specificity and sensitivity, ensuring accurate detection of CD117 antigen in tissue samples. This makes it a valuable tool in the diagnosis of GISTs and other CD117-related conditions.
2. The reagent is composed of CD117 rabbit monoclonal antibody and bovine serum albumin, which work together to provide consistent and reliable staining results. The formulation is optimized for use with formalin-fixed, paraffin-embedded tissues.
3. The primary use of this reagent is in the qualitative detection of CD117 antigen in human tissue sections. It is also used as a companion diagnostic for Imatinib therapy, helping to identify patients who may benefit from this targeted treatment.
The CD117 Antibody Reagent, also known as CD117 IHC Reagent or KIT Antibody Reagent, is a crucial tool in the field of immunohistochemistry. Its high specificity and sensitivity make it indispensable for diagnosing conditions like GISTs. The reagent's composition, including CD117 rabbit monoclonal antibody and bovine serum albumin, ensures reliable and consistent results. Its use in Imatinib therapy as a companion diagnostic further highlights its importance in personalized medicine.
The CD117 Antibody Reagent offers high specificity and sensitivity in detecting CD117 antigen, making it a reliable choice for immunohistochemical staining. Its optimized formulation ensures consistent results in clinical settings.
1. High specificity and sensitivity in detecting CD117 antigen, ensuring accurate diagnosis of conditions like GISTs.
2. Optimized for use with formalin-fixed, paraffin-embedded tissues, providing consistent staining results.
3. The reagent's composition includes CD117 rabbit monoclonal antibody and bovine serum albumin, which enhance its performance.
4. Used as a companion diagnostic for Imatinib therapy, aiding in the identification of suitable patients.
5. The reagent is easy to use and integrates seamlessly into existing immunohistochemistry protocols.
The CD117 Antibody Reagent stands out for its high specificity and sensitivity, making it a reliable tool for detecting CD117 antigen. Its optimized formulation and ease of use make it a valuable asset in clinical laboratories. The reagent's role as a companion diagnostic for Imatinib therapy further underscores its importance in personalized medicine.
The CD117 Antibody Reagent is widely used in clinical settings for the diagnosis of GISTs and other CD117-related conditions. Its role as a companion diagnostic for Imatinib therapy is particularly significant.
1. Used in the diagnosis of gastrointestinal stromal tumors (GISTs), where CD117 expression is a key diagnostic marker.
2. Employed in the identification of patients who may benefit from Imatinib therapy, a targeted treatment for GISTs.
3. Utilized in research settings to study the role of CD117 in various cancers and other diseases.
4. Applied in clinical trials to evaluate the efficacy of new treatments targeting CD117.
5. Used in routine clinical practice to provide accurate and reliable diagnostic information.
The CD117 Antibody Reagent plays a crucial role in the diagnosis and treatment of GISTs and other CD117-related conditions. Its application as a companion diagnostic for Imatinib therapy is particularly noteworthy, helping to identify patients who may benefit from this targeted treatment. The reagent's reliability and ease of use make it a valuable tool in both clinical and research settings.
When purchasing the CD117 Antibody Reagent, it is important to consider product specifications, types, budget, and intended use to ensure the best fit for your laboratory's needs.
1. Product parameters: Ensure the reagent is compatible with your laboratory's immunohistochemistry protocols and equipment.
2. Product types: Choose between different formulations and concentrations based on your specific diagnostic needs.
3. Budget: Consider the cost-effectiveness of the reagent, including any potential bulk purchase discounts.
4. Usage scenarios: Evaluate the reagent's performance in different clinical and research settings to ensure it meets your requirements.
Purchasing the CD117 Antibody Reagent requires careful consideration of product specifications, types, budget, and intended use. By evaluating these factors, you can ensure that the reagent is the best fit for your laboratory's needs, providing reliable and accurate results in your diagnostic and research applications.
Proper handling and storage of the CD117 Antibody Reagent are essential to maintain its efficacy and ensure accurate results. Follow all safety guidelines and manufacturer instructions.
1. Store the reagent at the recommended temperature to preserve its stability and performance.
2. Handle the reagent with care, using appropriate personal protective equipment to avoid contamination.
3. Follow the manufacturer's instructions for dilution and use to ensure optimal staining results.
4. Dispose of any unused reagent according to local regulations and safety guidelines.
5. Regularly check the reagent's expiration date and do not use it beyond this date to avoid unreliable results.
The CD117 Antibody Reagent requires careful handling and storage to maintain its efficacy. By following the manufacturer's instructions and safety guidelines, you can ensure that the reagent performs as expected, providing reliable and accurate results in your diagnostic and research applications. Proper disposal and regular checks of the expiration date are also crucial to avoid any potential issues.
We have the latest medical device product database in China, which can quickly meet your procurement needs.
Submit your purchase list, and we will reply to your inquiry within half an hour at the earliest.